Member Info for Tambo210

SO who would you punt as a buyer?

Market cap currently $1.1bn. SO someone would need to offer a premium.

What's the reason for them to sell? Have they got cash problems? If not, then a serious premium would need to be offered and I can't see that happening given their outlook on profitability (no update).

Its just following the US.

Awful fund BG Global Discovery.

WHen you look at their statement, and compare it against the benchmark they're trying to beat, you see how bad they are.

I think they're going to close that fund.

Antonvb - "I suspect Rahul doesn't know what is going on at the moment and neither to the Kenyans, as it's chaos over there. The joys of doing business in Africa."

WOW! I never thought you'd accept this fact.......but here we are!!!!

What's the timeline? Life sciences isn't doing so great at the moment and this could end up being a case of out of the frying pan and into the fire.

Just wait until interest rates start to fall.

The problem with the US is you can receive a de-listing noticing, almost forcing you to reverse split in order to get your stock price above $1.

Shorting on the US markets is brutal. UNless you're on the Pink Sheets, your market cap can be decimated and Life Sciences has been a victim of this, especially in high interest rate markets.

Now that they're in power, they can do what they want. Max pain!

I wouldn't be surprised if they tax Divis even if inside an ISA. Why not? If you're lucky enough to have money lying around to buy stocks, you can afford to pay a little more tax on the free shareholder returns!

Honestly! Anything's possible with this Labour government. They want to squeeze as much cash as they can out of everyone. No one is their friend. They were voted in with an overwhelming majority. They'll claim there's no money or insufficient funds to do what they want (Naive) and so 'we all need a period of sobriety and austerity'.

They'll lower the amount you can save in an ISA annually. They could tax ISA's with holdings more than £250k or something.

I hope that's true. I'm waiting for the results tomorrow to see if there's a dip before I round up my holding.

Sequencing market is in the doldrums at the moment. Spending is anaemic. Look at PacBio. They've pushed out their projections and pushed out their cash flow BE target. Their stock price is tentatively close to receiving a delisting notice which then results in the company performing a reverse split. Funds have dumped the stock, and it trades less than cash reported on hand (end of March).

I don't even think they can be bought out after ILMN failed.

Talking about ILMN, they installed 55 new Novaseq X machines and bagged a measly $110m in Q1'24 revs. Down nearly 30% Y-on-Y. PacBio managed 28 new installs of their high accuracy Revio. (They still won't declare numbers of Onso...which is probably the reason why the stock trades where it does).

ONT is aiming a slightly different set of customers rather than going for ILMN's complete install base.

They do need time and may be a capital raise.

Very good catch. That sort of news should propel ONT...

Https://www.electrive.com/2024/07/03/northvolt-reconsiders-expansion-plans/

It was 13 degrees below zero in Skellefteå in Sweden’s far north.

Arvid Öhgren, a contractor at Northvolt’s battery factory, tried to pull himself off the freezing ground.

He looked down and with his right hand tried to pick up his left arm. The limb was hanging by a thread of skin.

A sudden crane accident moments before had killed his co-worker, a man in his 60s.

As he waited for an ambulance, a panicked security guard said to Mr Öhgren: “It’s just a small fracture.”

“I didn’t really think much about the fact that the arm wasn’t there anymore,” he told Noran, Skellefteå’s local newspaper.

“All I really felt was that it hurt a hell of a lot.”

Mr Öhgren lost his arm and suffered a crushed foot.

This is just one of a series of tragic events to have plagued Northvolt, the Swedish battery start-up and European technology champion, in recent months.

As well as the death of Mr Öhgren’s co-worker on Dec 14 last year, another 25-year-old employee died as a result of an explosion on Nov 4.

Following news of the deaths, Peter Carlsson, the former Tesla executive leading Northvolt, said in December it was a “dark day” for the company.

Most battery companies are going to struggle to deliver on time /capacity with a global shift to predominantly BEV's.

JPMorgan cuts Legal & General price target to 285 (330) pence - 'overweight'

Https://www.reuters.com/business/autos-transportation/bmw-cancels-2-bln-contract-with-northvolt-says-handelsblatt-2024-06-20/

Antonvb - If Total walked away citing 'A complex mix of commercial, political, technical and environmental challenges ' then why would Shell, Petrobras, Sonagol, BP, Exxon, Chevron, etc come aboard? And make no mistake, the project needs someone like this. Having a smaller partner doesn't achieve much since they don't have deep pockets.

India’s ONGC Videsh and Indian Oil Corporation becoming “strategic” partners, is a sign that it wasn't compelling.

China’s Sinopec might come aboard since they like working in Africa. They can throw a lot of money at it, in return for the Government sending raw natural resources the other way as compensation. They'll probably demand a high share of the extracted oil.

TLW need to come up with the money for the development costs, and if that happens and oil fields developed, TLW will then have to share a larger than planned amount of oil revenues or they'll be taxed like mad.

Kenyan government knows TLW is not financially strong. Might as well make TLW sweat and hope they go BK so they can revoke the license

Brokers are self-serving. If the stock price drops for no apparent reason other than its fallen out of vogue, then a PT given 6months ago for the reasons they gave, will be reduced just to make their PT believable.

If LGEN is performing well (growing, paying a divi), but the market decides to plough their money into Mag 7 stocks, then LGEN will fall on the open market. In order for the Broker to earn their bonus, they'll adjust their PT to give a fighting chance of hitting their target.

In essence, move the goal posts.

You bought at a good price. Your choice whether you bank the divi or DRIP. If LGEN does turn out to be a bond proxy, then you'll benefit when interest rates drop.

Berenberg cuts Legal & General price target to 265 (289) pence - 'buy'

Barclays raises Legal & General price target to 320 (315) pence - 'overweight'

-UBS cuts Legal & General price target to 240 (258) pence - 'neutral'

No surprise Barclays raised the PT, given they are handling the buyback.

OK. Back in at 230.28. What I sold before xd, I gained 9.2% more in shares with the same funds. That's after 2 sets of commission, and stamp duty (Another reason why buying stocks in London isn't as popular as other countries).

I have a buy limit order set at 230p for 7 days. 50:50 whether it'll trigger. I've been wanting to buy back in since I sold at 250p pre xd.

Just an AGM

I'd say this year is a write off.

I'm now seeing a reason to double my stake in this. Its speculative, but if they can survive 2024 and 2025, then 2026 is when their fortune should change. But they need to maintain sales. Hopefully by then, Interest rates in the US will be more like 2%.

Whilst I have more money in PACB, , they themselves are experiencing some issues with regards to direction and execution.